Biofil Chemicals and Pharmaceuticals Limited (BSE: 524396)
Health Care · Pharmaceuticals · IN
Rs29.64
-9.50% today · -27.7% 1Y
Biofil Chemicals and Pharmaceuticals Limited (BSE: 524396) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.01M.
Over the last twelve months the share price has lost 27.7%, trading between 25.60 and 46.82.
Tweenvest scores Biofil Chemicals and Pharmaceuticals Limited across four factors: quality 64/100, value 67/100, growth 29/100. Its strongest factor is value.
524396 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.01M
- Revenue (TTM)
- $3.66M
- P/E
- 98.67
- EPS
- 0.30
- Dividend yield
- —
- Beta (5Y)
- 0.59
- 52-week high
- Rs46.82
- 52-week low
- Rs25.60
- Avg volume (3M)
- —
- Shares outstanding
- 16.27M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Rua Bioscience LimitedNZSE: RUA | $5.14M | NZ$0.03 | -6.90% |
| cbdMD, Inc.NYSEAM: YCBD | $5.11M | $0.39 | -13.42% |
| Percheron Therapeutics LimitedASX: PER | $5.07M | AU$0.00 | -11.11% |
| Panacea Life Sciences Holdings, Inc.OTCPK: PLSH | $5.06M | $0.09 | +6.25% |
| Enorama Pharma AB (publ)OM: ERMA | $4.97M | Skr0.61 | -8.96% |
| Vivimed Labs LimitedNSEI: VIVIMEDLAB | $4.92M | Rs5.71 | +2.88% |
| 60 Degrees Pharmaceuticals, Inc.NasdaqCM: SXTP | $4.89M | $0.97 | -30.04% |
| LIR Life Sciences Corp.CNSX: SKNY | $4.85M | CA$0.24 | +77.78% |
Figures last refreshed Oct 4, 2026.